Evidence map›Paper›PMID 34596019›Full record

SynthesisEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021

Spotlight influenza: Laboratory-confirmed seasonal influenza in people with acute respiratory illness: a literature review and meta-analysis, WHO European Region, 2004 to 2017.

Sara Belazi, Sonja J Olsen, Caroline Brown, Helen K Green, Piers Mook, Jonathan Nguyen-Van-Tam, Pasi Penttinen, Louise Lansbury

Open access · diamondAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Preparing for an influenza season 2021/22 with a likely co-circulation of influenza virus and SARS-CoV-2.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sara BelaziDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
Sonja J OlsenWHO Regional Office for Europe, Copenhagen, Denmark.
Caroline BrownWHO Regional Office for Europe, Copenhagen, Denmark.
Helen K GreenPublic Health England, London, United Kingdom.
Piers MookWHO Regional Office for Europe, Copenhagen, Denmark.
Jonathan Nguyen-Van-TamDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
Pasi PenttinenEuropean Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
Louise LansburyDivision of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom.
University of Nottingham · GBWorld Health Organization Regional Office for Europe · DKEuropean Centre for Disease Prevention and Control · SEPublic Health England · GB

Funding

World Health Organization 001
6 · The paper itself

Abstract

BackgroundAcross the World Health Organization European Region, there are few estimates of the proportion of people seeking medical care for influenza-like illness or acute respiratory infections and who have laboratory-confirmed seasonal influenza infection.MethodsWe conducted a meta-analysis of data extracted from studies published between 2004 and 2017 and from sentinel data from the European surveillance system (TESSy) between 2004 and 2018. We pooled within-season estimates by influenza type/subtype, setting (outpatient (OP)/inpatient (IP)) and age group to estimate the proportion of people tested who have laboratory-confirmed and medically-attended seasonal influenza in Europe.ResultsIn the literature review, the pooled proportion for all influenza types was 33% (95% confidence interval (CI): 30-36), higher among OP 36% (95% CI: 33-40) than IP 24% (95% CI: 20-29). Pooled estimates for all influenza types by age group were: 0-17 years, 26% (22-31); 18-64 years, 41% (32-50); ≥ 65 years, 33% (27-40). From TESSy data, 33% (31-34) of OP and 24% (21-27) of IP were positive. The highest proportion of influenza A was in people aged 18-64 years (22%, 16-29). By subtype, A(H1N1)pdm09 was highest in 18-64 year-olds (16%, 11-21%) whereas A(H3N2) was highest in those ≥ 65 years (10%, 2-22). For influenza B, the highest proportion of infections was in those aged 18-64 years (15%, 9-24).ConclusionsLaboratory-confirmed influenza accounted for approximately one third of all acute respiratory infections for which medical care was sought during the influenza season.

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanInfluenza VaccinesAdolescentCase-Control StudiesChildChild, PreschoolHumansInfantInfant, NewbornInfluenza A Virus, H3N2 SubtypeLaboratoriesSeasonsSentinel SurveillanceWorld Health OrganizationInfluenza Vaccinesacute respiratory infectioninfluenza A virusinfluenza B virusinfluenza humaninfluenza-like illnessmedically-attended

Identifiers

PMID34596019
PMCPMC8485580
OpenAlexW3203552591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.